Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 3/2015

01.06.2015 | Research Article

Consumers’ perception of generic substitution in Iran

verfasst von: Nazila Yousefi, Gholamhossein Mehralian, Farzad Peiravian, Samaneh NourMohammadi

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background The growth of pharmaceutical expenditure and patients’ out of pocket has motivated policy makers to encourage patients to substitution of brands medicines with their generic alternatives called generic substitution. Objectives As the patients are final decision makers to accept generic substitution, the aim of this study is to evaluate the patient perception about generic medicines and underlying factors which can promote the generic acceptance. Setting The study was done in community pharmacies in Tehran, the capital city of Iran. Method A cross-sectional descriptive study inviting people purchasing their drug at community pharmacies were per-formed using a self-administrated anonymous questionnaire (N=1309). Main outcomes measures besides the demographic section, 16 items of developed questionnaire were categorized to five main factors including: patients’ perception about efficiency, safety and cost of generic medicines, patient trust on physicians and pharmacists’ advice. Results Findings of completed questionnaires showed among the aforementioned factors the physician has the first priority to encourage patients to use of generics medicines which followed respectively by pharmacist’s role, cost of medicines, efficacy, and safety concerns. Conclusion In conclusion, the trust of Iranian’s society on the physicians and pharmacists advice would create a credible opportunity to reduce pharmaceutical expenditures as well as patients’ out of pocket by promotion of generic substitution.
Literatur
1.
Zurück zum Zitat Thomas R. Health services demand and utilization. Health services planning. New York, US: Springer; 2003.CrossRef Thomas R. Health services demand and utilization. Health services planning. New York, US: Springer; 2003.CrossRef
2.
Zurück zum Zitat Smith RD, Correa C, Oh C. Trade, TRIPS and Pharmaceuticals. Lancet 2009;373:684–91. Smith RD, Correa C, Oh C. Trade, TRIPS and Pharmaceuticals. Lancet 2009;373:684–91.
3.
Zurück zum Zitat Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics. 2003;21(2):89–103.CrossRefPubMed Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics. 2003;21(2):89–103.CrossRefPubMed
4.
Zurück zum Zitat McManus P, Birkett DJ, Dudley J, Stevens A. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia. Pharmacoepidemiol Drug Saf. 2001;10(4):295–300.CrossRefPubMed McManus P, Birkett DJ, Dudley J, Stevens A. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia. Pharmacoepidemiol Drug Saf. 2001;10(4):295–300.CrossRefPubMed
5.
Zurück zum Zitat Hassali MA, Shafie AA, Chong CP, Saleem F, Atif M, Chua G, et al. Community pharmacist’s perceptions towards the quality of locally manufactured generic medicines: a descriptive study from Malaysia. J Appl Pharm Sci. 2012;2(1):56–60. Hassali MA, Shafie AA, Chong CP, Saleem F, Atif M, Chua G, et al. Community pharmacist’s perceptions towards the quality of locally manufactured generic medicines: a descriptive study from Malaysia. J Appl Pharm Sci. 2012;2(1):56–60.
6.
Zurück zum Zitat Abdollahiasl A. Medicine prices, availability, affordability and price component. In: IranFDO, editor. World Health Organization; 2010. Abdollahiasl A. Medicine prices, availability, affordability and price component. In: IranFDO, editor. World Health Organization; 2010.
8.
Zurück zum Zitat Jamshed S, Babar Z, Ibrahim M, Hassali M. Generic medicines as a way to improve access and affordability: a proposed framework for Pakistan. J Clin Diagn Res. 2009;3(3):1596–600. Jamshed S, Babar Z, Ibrahim M, Hassali M. Generic medicines as a way to improve access and affordability: a proposed framework for Pakistan. J Clin Diagn Res. 2009;3(3):1596–600.
9.
Zurück zum Zitat Omojasola A, Hernandez M, Sansgiry S, Jones L. Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012;22(4):479.PubMedCentralPubMed Omojasola A, Hernandez M, Sansgiry S, Jones L. Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012;22(4):479.PubMedCentralPubMed
10.
Zurück zum Zitat Galizzi MM, Ghislandi S, Miraldo M. Effects of reference pricing in pharmaceutical markets. Pharmacoeconomics. 2011;29(1):17–33.CrossRefPubMed Galizzi MM, Ghislandi S, Miraldo M. Effects of reference pricing in pharmaceutical markets. Pharmacoeconomics. 2011;29(1):17–33.CrossRefPubMed
11.
Zurück zum Zitat Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007;85(4):279–88.CrossRefPubMedCentralPubMed Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007;85(4):279–88.CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Barros PP, Nunes LC. The impact of pharmaceutical policy measures: an endogenous structural-break approach. Soc Sci Med. 2010;71(3):440–50.CrossRefPubMed Barros PP, Nunes LC. The impact of pharmaceutical policy measures: an endogenous structural-break approach. Soc Sci Med. 2010;71(3):440–50.CrossRefPubMed
13.
Zurück zum Zitat Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48.CrossRefPubMed Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48.CrossRefPubMed
14.
Zurück zum Zitat Babar Z-U-D, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci. 2010;32(4):440–8.CrossRefPubMed Babar Z-U-D, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci. 2010;32(4):440–8.CrossRefPubMed
15.
Zurück zum Zitat Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study. Res Soc Adm Pharm. 2011;7(1):108–12.CrossRef Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study. Res Soc Adm Pharm. 2011;7(1):108–12.CrossRef
16.
Zurück zum Zitat IranFDO. Pharmaceutical statistics. Food and drug organization of iranian Ministry of Health, Iran; 2013. IranFDO. Pharmaceutical statistics. Food and drug organization of iranian Ministry of Health, Iran; 2013.
17.
Zurück zum Zitat Heikkilä R, Mäntyselkä P, Ahonen R. Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland. Drugs Ther Perspect. 2012;28(8):24–6. Heikkilä R, Mäntyselkä P, Ahonen R. Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland. Drugs Ther Perspect. 2012;28(8):24–6.
18.
Zurück zum Zitat Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: How much could be saved? Value Health. 2012;15(5):664–73.CrossRefPubMed Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: How much could be saved? Value Health. 2012;15(5):664–73.CrossRefPubMed
19.
Zurück zum Zitat Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers’ views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17(2):79–88.PubMed Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers’ views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17(2):79–88.PubMed
20.
Zurück zum Zitat King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9.PubMed King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9.PubMed
21.
Zurück zum Zitat Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen R-D, Kochen M, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472.CrossRefPubMed Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen R-D, Kochen M, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472.CrossRefPubMed
22.
Zurück zum Zitat Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed
23.
Zurück zum Zitat Meredith PA. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms. Curr Med Res Opin. 2009;25(9):2179–89.CrossRefPubMed Meredith PA. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms. Curr Med Res Opin. 2009;25(9):2179–89.CrossRefPubMed
24.
Zurück zum Zitat Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012;104(1):61–8.CrossRefPubMed Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012;104(1):61–8.CrossRefPubMed
25.
Zurück zum Zitat Heikkilä R, Mäntyselkä P, Ahonen R. Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol Drug Saf. 2011;20(2):185–91.CrossRefPubMed Heikkilä R, Mäntyselkä P, Ahonen R. Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol Drug Saf. 2011;20(2):185–91.CrossRefPubMed
26.
Zurück zum Zitat Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.CrossRefPubMed Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.CrossRefPubMed
27.
Zurück zum Zitat Heikkilä R, Mäntyselkä P, Ahonen R. Price, familiarity, and availability determine the choice of drug-a population-based survey five years after generic substitution was introduced in Finland. BMC Pharmacol Toxicol. 2011;11(1):20. Heikkilä R, Mäntyselkä P, Ahonen R. Price, familiarity, and availability determine the choice of drug-a population-based survey five years after generic substitution was introduced in Finland. BMC Pharmacol Toxicol. 2011;11(1):20.
28.
Zurück zum Zitat Lambert ZV, Doering PL, Goldstein E, McCormick WC. Predispositions toward generic drug acceptance. J Consum Res. 1980;7(1):14–23. Lambert ZV, Doering PL, Goldstein E, McCormick WC. Predispositions toward generic drug acceptance. J Consum Res. 1980;7(1):14–23.
29.
Zurück zum Zitat Gaither CA, Kirking DM, Ascione FJ, Welage LS. Science & practice-reviews-consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36. Gaither CA, Kirking DM, Ascione FJ, Welage LS. Science & practice-reviews-consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36.
30.
Zurück zum Zitat Rathe J, Larsen P, Andersen M, Paulsen M, Jarbøl D, Thomsen J, et al. Associations between generic substitution and patients’ attitudes, beliefs and experiences. Eur J Clin Pharmacol. 2013;69(10):1827–36.CrossRefPubMed Rathe J, Larsen P, Andersen M, Paulsen M, Jarbøl D, Thomsen J, et al. Associations between generic substitution and patients’ attitudes, beliefs and experiences. Eur J Clin Pharmacol. 2013;69(10):1827–36.CrossRefPubMed
31.
Zurück zum Zitat Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202.CrossRefPubMed Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202.CrossRefPubMed
32.
Zurück zum Zitat Shepherd M. Consumer drug purchases are based on perceptions of quality, survey on generics finds. Am J Hosp Pharm. 1988;45:1245. Shepherd M. Consumer drug purchases are based on perceptions of quality, survey on generics finds. Am J Hosp Pharm. 1988;45:1245.
33.
Zurück zum Zitat Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6(2):93–7. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6(2):93–7.
34.
Zurück zum Zitat Figueiras MJ, Marcelino D, Cortes MA. People’s views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590–4.CrossRefPubMed Figueiras MJ, Marcelino D, Cortes MA. People’s views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590–4.CrossRefPubMed
35.
Zurück zum Zitat Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. Am Pharm. 1999;40(3):378–83. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. Am Pharm. 1999;40(3):378–83.
36.
Zurück zum Zitat Mehralian G, Rangchian M, Rasekh HR. Client priorities and satisfaction with community pharmacies: the situation in Tehran. Int J Clin Pharm. 2014;36(4):707–15.CrossRefPubMed Mehralian G, Rangchian M, Rasekh HR. Client priorities and satisfaction with community pharmacies: the situation in Tehran. Int J Clin Pharm. 2014;36(4):707–15.CrossRefPubMed
37.
Zurück zum Zitat Mehralian G, Rangchian M, Javadi A, Peiravian F. Investigation on barriers to pharmaceutical care in community pharmacies: a structural equation model. Int J Clin Pharm. 2014;36(5):1087–94. Mehralian G, Rangchian M, Javadi A, Peiravian F. Investigation on barriers to pharmaceutical care in community pharmacies: a structural equation model. Int J Clin Pharm. 2014;36(5):1087–94.
38.
Zurück zum Zitat Mehralian G, Yousefi N, Hashemian F, Maleksabet H. knowledge, attitude and practice regarding dietary supplements: a community pharmacy-based survey in Tehran. Iran J Pharm Res. 2014;13(4):1455–63. Mehralian G, Yousefi N, Hashemian F, Maleksabet H. knowledge, attitude and practice regarding dietary supplements: a community pharmacy-based survey in Tehran. Iran J Pharm Res. 2014;13(4):1455–63.
39.
Zurück zum Zitat Ud-Din Babar Z, Grover P, Butler R, Bye L, Sheridan J. A qualitative evaluation of general practitioners’ perceptions regarding access to medicines in New Zealand. BMJ Open 2012;2:e000518PubMedCentralPubMed Ud-Din Babar Z, Grover P, Butler R, Bye L, Sheridan J. A qualitative evaluation of general practitioners’ perceptions regarding access to medicines in New Zealand. BMJ Open 2012;2:e000518PubMedCentralPubMed
Metadaten
Titel
Consumers’ perception of generic substitution in Iran
verfasst von
Nazila Yousefi
Gholamhossein Mehralian
Farzad Peiravian
Samaneh NourMohammadi
Publikationsdatum
01.06.2015
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2015
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0085-4

Weitere Artikel der Ausgabe 3/2015

International Journal of Clinical Pharmacy 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.